Micromedic Technologies / SRL Diagnostics

Results

• 180 patients enrolled in the pilot
• 130 sets of cervical smears from women at the age range of 27-75 years were prepared.
• 109 were considered normal and 21 were considered suspicious with both staining methods.
• This pilot demonstrated that the time spent to interpret a CellDetect® slide was significantly shorter compared to the time spent to analyze a standard Pap smear.
• By reducing the time required to analyze each cervical slide, CellDetect® generates a significant increase in overall throughput and assists in lowering the screening burden of cervical smears.

• The CellDetect® color feature was considered useful in the majority of the suspicious cases and slide interpretation was deemed simplified in most of these cases.

• The use of color not only adds to morphology but also adds a new dimension in interpretation of suspicious cases that helps increase the throughput and improve patient diagnosis. 

Lessons Learned

• The CellDetect® kit was easier to operate than the team originally anticipated. Remote training and support were effective and sufficient.
• The program opened the opportunity to enter the Indian market and explore the local need for the product.